J B Ernst1, A Zittermann2, S Pilz3,4, M E Kleber5, H Scharnagl6, V M Brandenburg7, W König8, T B Grammer5,9, W März5,6,10. 1. Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany. 2. Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany. azittermann@hdz-nrw.de. 3. Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria. 4. Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands. 5. Medical Clinic V (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology) Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany. 6. Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. 7. Department of Cardiology, University Hospital of the RWTH Aachen, Aachen, Germany. 8. Department of Internal Medicine II - Cardiology, University of Ulm, Ulm, Germany. 9. Mannheim Institute of Public Health, Social and Preventive Medicine, Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany. 10. Synlab Academy, Synlab Laboratory Services GmbH, Mannheim, Germany.
Abstract
PURPOSE: Anemia and vitamin D deficiency are both frequent in adult patients. Whether low vitamin D metabolite levels are an independent risk factor for different subtypes of anemia remains to be studied in detail. METHODS: In 3299 patients referred for coronary angiography, we investigated the association of 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D [1,25(OH)2D] with anemia [hemoglobin (Hb) <12.5 g/dl] of specific subtypes. RESULTS: Compared with patients with 25OHD levels in the adequate range (50-125 nmol/l), patients with deficient 25OHD concentrations (<30 nmol/l; 33.6 % of patients) had 0.6 g/dl lower Hb levels. Hb values were 1.3 g/dl lower in patients with 1,25(OH)2D levels <40 pmol/l (5.4 % of patients), compared with patients in the highest 1,25(OH)2D category (>70 pmol/l). Of the participants, 16.7 % met the criteria for anemia. In multivariate-adjusted regression analyses, the odds ratios for anemia in the lowest 25OHD and 1,25(OH)2D categories were 1.52 (95 % CI 1.15-2.02) and 3.59 (95 % CI 2.33-5.52), compared with patients with 25OHD levels in the adequate range and patients with 1,25(OH)2D levels >70 pmol/l. The probability of anemia was highest in patients with combined 25OHD and 1,25(OH)2D deficiency [multivariable-adjusted odds ratio 5.11 (95 % CI 2.66-9.81)]. Patients with anemia of chronic kidney disease had the highest prevalence of 25OHD deficiency and 1,25(OH)2D concentrations of <40 pmol/l. CONCLUSIONS: Low 25OHD and 1,25(OH)2D concentrations are independently associated with anemia. Patients with poor kidney function are most affected. Interventional trials are warranted to prove whether administration of plain or activated vitamin D can prevent anemia.
PURPOSE:Anemia and vitamin D deficiency are both frequent in adult patients. Whether low vitamin D metabolite levels are an independent risk factor for different subtypes of anemia remains to be studied in detail. METHODS: In 3299 patients referred for coronary angiography, we investigated the association of 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D [1,25(OH)2D] with anemia [hemoglobin (Hb) <12.5 g/dl] of specific subtypes. RESULTS: Compared with patients with 25OHD levels in the adequate range (50-125 nmol/l), patients with deficient 25OHD concentrations (<30 nmol/l; 33.6 % of patients) had 0.6 g/dl lower Hb levels. Hb values were 1.3 g/dl lower in patients with 1,25(OH)2D levels <40 pmol/l (5.4 % of patients), compared with patients in the highest 1,25(OH)2D category (>70 pmol/l). Of the participants, 16.7 % met the criteria for anemia. In multivariate-adjusted regression analyses, the odds ratios for anemia in the lowest 25OHD and 1,25(OH)2D categories were 1.52 (95 % CI 1.15-2.02) and 3.59 (95 % CI 2.33-5.52), compared with patients with 25OHD levels in the adequate range and patients with 1,25(OH)2D levels >70 pmol/l. The probability of anemia was highest in patients with combined 25OHD and 1,25(OH)2D deficiency [multivariable-adjusted odds ratio 5.11 (95 % CI 2.66-9.81)]. Patients with anemia of chronic kidney disease had the highest prevalence of 25OHD deficiency and 1,25(OH)2D concentrations of <40 pmol/l. CONCLUSIONS: Low 25OHD and 1,25(OH)2D concentrations are independently associated with anemia. Patients with poor kidney function are most affected. Interventional trials are warranted to prove whether administration of plain or activated vitamin D can prevent anemia.
Authors: Vasant Hirani; Robert G Cumming; Fiona Blyth; Vasi Naganathan; David G Le Couteur; Louise M Waite; David J Handelsman; Markus J Seibel Journal: Age (Dordr) Date: 2015-02-04
Authors: Pedro L Neves; Julio Triviño; Francisco Casaubon; Viriato Santos; Patricia Mendes; Paulo Romão; Isilda Bexiga; Idalécio Bernardo Journal: Int Urol Nephrol Date: 2006 Impact factor: 2.370
Authors: William McClellan; Stephen L Aronoff; W Kline Bolton; Sally Hood; Daniel L Lorber; K Linda Tang; Thomas F Tse; Brian Wasserman; Marc Leiserowitz Journal: Curr Med Res Opin Date: 2004-09 Impact factor: 2.580
Authors: Ellen M Smith; Jennifer L Jones; Jenny E Han; Jessica A Alvarez; John H Sloan; Robert J Konrad; Susu M Zughaier; Greg S Martin; Thomas R Ziegler; Vin Tangpricha Journal: JPEN J Parenter Enteral Nutr Date: 2017-12-11 Impact factor: 4.016
Authors: J B Ernst; S Prokop; U Fuchs; J Dreier; J Kuhn; C Knabbe; H K Berthold; S Pilz; I Gouni-Berthold; J F Gummert; J Börgermann; A Zittermann Journal: Nutr J Date: 2017-08-23 Impact factor: 3.271
Authors: Ellen S Michalski; Phuong H Nguyen; Ines Gonzalez-Casanova; Son V Nguyen; Reynaldo Martorell; Vin Tangpricha; Usha Ramakrishnan Journal: J Clin Transl Endocrinol Date: 2017-05-04
Authors: Mohammad S Masoud; Majed S Alokail; Sobhy M Yakout; Malak Nawaz K Khattak; Marwan M AlRehaili; Kaiser Wani; Nasser M Al-Daghri Journal: Nutrients Date: 2018-12-02 Impact factor: 5.717
Authors: Vanessa De la Cruz-Góngora; Aarón Salinas-Rodríguez; Mario Flores-Aldana; Salvador Villalpando Journal: Nutrients Date: 2021-10-27 Impact factor: 5.717